Delivery Order SPE2DR25D9113-SPE2DR26FCHY7

<p>The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, for $12,720.92 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 5 mg tablets (60-count units).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The ultimate completion date is February 25, 2026. The order is firm fixed price with no set-aside designation.</p>

The Defense Logistics Agency issued a $12,603.07 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, for JAKAFI 25 mg tablets (60-count unit). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations...

The Defense Logistics Agency issued a $25,326.56 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order has a firm fixed-price structure with an ultimate completion date of March 3, 2026. The PPV-G GEN V is a Defense Logistics Agency...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, with a ceiling value of $25,326.56 for supply of JAKAFI 10 mg tablets (60 count), with ultimate completion by March 2, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceuticals and medical consumables to support military...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $18,516.41 for supply of JAKAFI 5 mg tablets (60 count) under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of February 10, 2026. PPV-G GEN V...

The Defense Logistics Agency issued a $12,663.27 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for JAKAFI 10 mg tablets (60 count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense...

The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for supply of Jakafi 5 mg tablets (60-count) under firm fixed-price terms. DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499,999,999 ceiling. Place of performance is Park...

The Defense Logistics Agency awarded a $37,989.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). The award, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, was made without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This...

The Defense Logistics Agency awarded a $48,462.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count packages). The contract, executed on October 31, 2025, with an ultimate completion date of November 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award was issued under DMS Pharmaceutical Group's single-award...

The Defense Logistics Agency issued a $25,441.84 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for supply of Jakafi 5 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency-administered indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a $499.999 billion...